JQ1 could be used for regulating transcription of c‐Myc and PD‐L1 and PDT‐mediated ICD significantly regressed primary and distant tumors (Figure 5b), which resulted in prolonging the survival of Panc02‐pancreatic tumor‐bearing mice.[136] HA was used for actively targeting tumors via specific binding to the CD44 receptor on the tumor cell surface and prolonging the blood circulation time of the nanoplatform up to 48 h. Here, CD274 is linked to neoplasm.